Cambrian Genomics

Cambrian Genomics was a biotechnology company founded in 2011 in San Francisco, California.

The company specialized in a unique laser-based technique for synthesizing and printing DNA, aiming to innovate the DNA production market, which is valued at over $1 billion annually. Cambrian Genomics focused on providing high-quality, sequence-verified DNA through advanced hardware systems that combined various scientific disciplines, including polymer chemistry, optics, and synthetic biology. The company's core technology involved laser printing of DNA, which allowed for rapid synthesis of genetic material for genomics research. This included applications in genome decoding, editing, and manipulation. Cambrian Genomics offered custom DNA synthesis and printing services, targeting academic researchers, pharmaceutical companies, and biotech firms. It also provided genomic sequencing and editing tools for medical research and drug development. The company collaborated with notable firms such as Roche, GlaxoSmithKline, and Thermo Fisher Scientific, contributing to projects like the 2013 Glowing Plant Kickstarter initiative.